期刊文献+

Assessment of the immune responses to Treponema pallidum Gpd DNA vaccine adjuvanted with IL-2 and chitosan nanoparticles before and after Treponema pallidum challenge in rabbits 被引量:10

Assessment of the immune responses to Treponema pallidum Gpd DNA vaccine adjuvanted with IL-2 and chitosan nanoparticles before and after Treponema pallidum challenge in rabbits
原文传递
导出
摘要 Syphilis is a multistage,sexually transmitted disease caused by the spirochete,Treponema pallidum(Tp).A significantly high incidence of syphilis has been reported in several countries,including China,and there is an urgent need for the development of efficacious vaccines against syphilis.DNA vaccines are a major breakthrough in the field of vaccination with several advantages over traditional vaccines.Animal model studies of Tp DNA vaccines have not been reported elsewhere but our previous reports describe the development of a single-gene Tp DNA vaccine and preclinical immunization study.In this study,chitosan(CS) nanoparticles were used as a vector and an interleukin-2 expression plasmid(pIL-2) as an adjuvant to enhance a TpGpd DNA vaccine candidate(pTpGpd) in a rabbit Tp skin challenge model.At week 8 after the first immunization,three rabbits from each group were used to determine cytokine measurements and spleen lymphocyte proliferation assay.pTpGpd in combination with pIL-2 wrapped with CS led to the greatest enhancement of anti-TpGpd antibodies and T-cell proliferation.During infection,levels of anti-TpGpd antibodies and T-cell proliferation were measured.Both the serum special IgG and IL-2,interferon-γ were significantly increased by the co-injection of the IL-2 plasmid compared with the injection of TpGpd DNA alone(P<0.05).Furthermore,IL-2 plasmid coinjection efficiently enhanced the antigen-specific lymphocyte proliferation response.Additionally,the ratios of positive skin lesions and ulcer lesions in groups immunized with pTpGpd were significantly lower than those of the pIL-2,CS or pIL-2 mixed with CS control groups(P<0.001).CS vectored and pIL-2 adjuvanted pTpGpd immunized animals exhibited the lowest rates of positive skin tests(8.33%) and ulcer lesions(4.17%) and the fastest recovery(42 d).These experiments indicate that co-injection of a pIL-2 plasmid with pTpGpd DNA vaccine wrapped with CS can significantly strengthen the long-term stability of immune response during infection,efficiently improve Syphilis is a multistage, sexually transmitted disease caused by the spirochete, Treponema pallidum (Tp). A significantly high incidence of syphilis has been reported in several countries, including China, and there is an urgent need for the development of efficacious vaccines against syphilis. DNA vaccines are a major breakthrough in the field of vaccination with several advantages over traditional vaccines. Animal model studies of Tp DNA vaccines have not been reported elsewhere but our previous reports describe the development of a single-gene Tp DNA vaccine and preclinical immunization study. In this study, chitosan (CS) nanoparticles were used as a vector and an interleukin-2 expression plasmid (pIL-2) as an adjuvant to enhance a TpGpd DNA vaccine candidate (pTpGpd) in a rabbit Tp skin challenge model. At week 8 after the first immunization, three rabbits from each group were used to determine cytokine measurements and spleen lymphocyte proliferation assay, pTpGpd in combination with pIL-2 wrapped with CS led to the greatest enhancement of anti-TpGpd antibodies and T-cell proliferation. During infection, levels of anti-TpGpd antibodies and T-cell proliferation were measured. Both the serum special IgG and IL-2, interferon-γ, were significantly increased by the co-injection of the IL-2 plasmid compared with the injection of TpGpd DNA alone (P〈0.05). Furthermore, IL-2 plasmid coinjection efficiently enhanced the antigen-specific lymphocyte proliferation response. Additionally, the ratios of positive skin lesions and ulcer lesions in groups immunized with pTpGpd were significantly lower than those of the pIL-2, CS or pIL-2 mixed with CS control groups (P〈0.001). CS vectored and pIL-2 adjuvanted pTpGpd immunized animals exhibited the lowest rates of positive skin tests (8.33%) and ulcer lesions (4.17%) and the fastest recovery (42 d). These experiments indicate that co-injection of a pIL-2 plasmid with pTpGpd DNA vaccine wrapped with CS can significantly strengthen the lo
出处 《Science China(Life Sciences)》 SCIE CAS 2013年第2期174-180,共7页 中国科学(生命科学英文版)
基金 supported by the Foundation of Hunan Province Science and Technology Department,China (2010FJ2008,2012TT2006) the Natural Science Foundation of Hunan Province Science and Technology Department,China (11JJ9023) the Foundation of Hunan Province Education Department,China (11B107)
关键词 Treponema pailidum (Tp) membrane protein GPD CS IL-2 nucleic acid vaccine 梅毒螺旋体 DNA疫苗 IL-2 免疫应答 脱乙酰壳多糖 佐剂 纳米颗粒 兔子
  • 相关文献

参考文献2

二级参考文献44

  • 1Lee S,Hong J,Choi S Y,et al.(2004).CpG oligodeoxynucleotides induce expression of proinflammatory cytokines and chemokines in astrocytes:the role of c-Jun N-terminal kinase in CpG ODN-mediated NF-kappaB activation.J Neuroimmunol 153(1-2),50-63. 被引量:1
  • 2Klinman,D M,Currie,D,Gursel,I,et al.(2004).Use of CpG oligodeoxynucleotides as immune adjuvants.Immunol Rev 199,201-216. 被引量:1
  • 3Sandler A D,Chihara H,Kobayashi G,et al.(2003).CpG Oligonucleotides Enhance the Tumor Antigen-specific Immune Response of a Granulocyte Macrophage Colony-stimulating Factor-based Vaccine Strategy in Neuroblastoma.Cancer Res 63,394-399. 被引量:1
  • 4Dastan T,Turan K (2004).In vitro characterization and delivery of chitosan-DNA microparticles into mammalian cells.J Pharm Pharm Sci 7(2),205-214. 被引量:1
  • 5Gupta K C,Ravi Kumar M N (2000).Drug release behavior of beads and microgranules of chitosan.Biomaterials 21(11),1115-1119. 被引量:1
  • 6Illum L (1998).Chitosan and its use as a pharmaceutical excipient.Pharm Res 15,1326-1331. 被引量:1
  • 7Janes K A,Calvo P,Alonso M J (2001).Polysaccharide colloidal particles as delivery systems for macromolecules.Adv Drug Delivery Rev 47(1),83-97. 被引量:1
  • 8Bodmeier R,Chen H G,Paeratakul O (1989).A novel approach to the delivery of micro or nanoparticles.Pharm Res 6(5),413-417. 被引量:1
  • 9Battikhi M N (2003).Occurrence of Salmonella typhi and Salmonella paratyphi in Jordan.New Microbiol 26(4),363-373. 被引量:1
  • 10Ahmed A M,Furuta K,Shimomura K,et al.(2005).Characterization of a multidrug-resistant isolate of Salmonella Paratyphi B from Japan.J Antimicrob Chemother 10,Epub ahead of print. 被引量:1

共引文献7

同被引文献21

引证文献10

二级引证文献60

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部